Trial NCT05303584
Publication Tang R, Lancet Resp Med, 2023
Dates: 2022-04-23 to 2022-05-23
Funding: Mixed (National Natural Science Foundation of China, Jiangsu Provincial Science Fund for Distinguished Young Scholars, and Jiangsu Provincial Key Project of Science and Technology Plan. Jin-Bo Gou, Haitao Huang, Xiaolong Li, Xue Wang, Peng Wan and Tao Zhu are employees of CanSino Biologics. Tao Zhu owns stock in CanSino Biologics. )
Conflict of interest: Yes